Evoke Pharma, Inc. (EVOK): Price and Financial Metrics
EVOK Price/Volume Stats
| Current price | $5.07 | 52-week high | $14.16 |
| Prev. close | $5.49 | 52-week low | $3.54 |
| Day low | $4.81 | Volume | 53,200 |
| Day high | $5.38 | Avg. volume | 119,953 |
| 50-day MA | $4.97 | Dividend yield | N/A |
| 200-day MA | $5.60 | Market Cap | 7.53M |
EVOK Stock Price Chart Interactive Chart >
Evoke Pharma, Inc. (EVOK) Company Bio
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase III clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in women. The company was founded in 2007 and is headquartered in Solana Beach, California.
EVOK Price Returns
| 1-mo | 12.67% |
| 3-mo | 12.42% |
| 6-mo | -24.69% |
| 1-year | -63.26% |
| 3-year | -94.21% |
| 5-year | -97.65% |
| YTD | -59.77% |
| 2023 | -60.81% |
| 2022 | -59.39% |
| 2021 | -78.68% |
| 2020 | 59.26% |
| 2019 | -34.68% |
Loading social stream, please wait...